TianYu Bio-Technology Balance Sheet Health
Financial Health criteria checks 4/6
TianYu Bio-Technology has a total shareholder equity of CN¥879.1M and total debt of CN¥905.7M, which brings its debt-to-equity ratio to 103%. Its total assets and total liabilities are CN¥3.3B and CN¥2.4B respectively.
Key information
103.0%
Debt to equity ratio
CN¥905.67m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥165.32m |
| Equity | CN¥879.11m |
| Total liabilities | CN¥2.40b |
| Total assets | CN¥3.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603717's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 603717's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥1.2B).
Debt to Equity History and Analysis
Debt Level: 603717's net debt to equity ratio (84.2%) is considered high.
Reducing Debt: 603717's debt to equity ratio has increased from 56.5% to 103% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 603717 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 603717 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 4.9% per year.